Benjamin Looker Receives Stock Award at Trillium Therapeutics Inc (TRIL) — SEC Form 4, May 05, 2021
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Benjamin Looker CIK 0001859509 |
GC
|
Benjamin Looker at Trillium Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Trillium Therapeutics Inc
| 2021-11-19 | - | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.51 | 2021-05-03 | A - Award/Grant | 190,000 A | $0.00 | 2031-05-03 | 190,000 Common Shares | Direct |
Footnotes (1)
- F1
- 25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months. Show more
Related filings at Trillium Therapeutics Inc
Other insiders at Trillium Therapeutics Inc
GET /v1/forms/4/0001062993-21-004147
API docs
View Original SEC Filing